• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大呼吸道合胞病毒住院负担

Burden of Respiratory Syncytial Virus Hospitalizations in Canada.

作者信息

Mitchell Ian, Defoy Isabelle, Grubb ElizaBeth

机构信息

Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB, Canada T6B 6A8.

AbbVie Corporation, 8401 Trans-Canada Highway, Saint-Laurent, QC, Canada H4S 1Z1.

出版信息

Can Respir J. 2017;2017:4521302. doi: 10.1155/2017/4521302. Epub 2017 Nov 7.

DOI:10.1155/2017/4521302
PMID:29311757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5697123/
Abstract

OBJECTIVE

To examine the socioeconomic burden of respiratory syncytial virus (RSV) disease for Canadian infants hospitalized for the condition.

DATA AND METHODS

The descriptive study used data collected in Alberta, Canada, during 2 consecutive RSV seasons. Infants (<1 year of age) were included if they had not received palivizumab and were hospitalized with a confirmed diagnosis of RSV. Hospitalization resource use and parental time burden, out-of-pocket costs, lost work productivity, and stress and anxiety were assessed.

RESULTS

13.4% of all infants ( = 67) had intensive care unit (ICU) admission, and average ICU stay for these infants was 6.5 days. Families had average out-of-pocket expenses of 736.69 Canadian dollars (CAD $), and the average time both parents spent in hospital was nearly 7 days (164.0 hours). For working parents ( = 43), average absenteeism was 49% and overall work impairment was 77.8%. Parents also exhibited significant parental stress (3.6 on the Parental Stressor Scale: 43.9 state anxiety and 36.9 trait anxiety scores).

CONCLUSIONS

Results indicate a high burden associated with the hospitalization of an infant due to RSV disease in terms of resource use, time, productivity, costs, and stress, even among a population of infants not considered to be at risk for the condition.

摘要

目的

研究呼吸道合胞病毒(RSV)疾病给因该疾病住院的加拿大婴儿带来的社会经济负担。

数据与方法

这项描述性研究使用了加拿大艾伯塔省在连续两个RSV流行季节收集的数据。纳入未接受帕利珠单抗治疗且确诊为RSV感染而住院的1岁以下婴儿。评估了住院资源使用情况、父母的时间负担、自付费用、工作生产力损失以及压力和焦虑情况。

结果

所有婴儿中13.4%(n = 67)入住了重症监护病房(ICU),这些婴儿在ICU的平均住院时间为6.5天。家庭平均自付费用为736.69加元(CAD $),父母双方在医院花费的平均时间接近7天(164.0小时)。对于有工作的父母(n = 43),平均缺勤率为49%,总体工作受损率为77.8%。父母还表现出显著的父母压力(父母压力量表评分为3.6:状态焦虑得分43.9,特质焦虑得分36.9)。

结论

结果表明,即使在被认为没有该疾病风险的婴儿群体中,因RSV疾病导致婴儿住院在资源使用、时间、生产力、成本和压力方面也会带来很高的负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/5697123/db1dbc977e16/CRJ2017-4521302.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/5697123/5cc1127bd3d2/CRJ2017-4521302.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/5697123/c460b3e73ec9/CRJ2017-4521302.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/5697123/0278852106cd/CRJ2017-4521302.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/5697123/db1dbc977e16/CRJ2017-4521302.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/5697123/5cc1127bd3d2/CRJ2017-4521302.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/5697123/c460b3e73ec9/CRJ2017-4521302.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/5697123/0278852106cd/CRJ2017-4521302.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0518/5697123/db1dbc977e16/CRJ2017-4521302.004.jpg

相似文献

1
Burden of Respiratory Syncytial Virus Hospitalizations in Canada.加拿大呼吸道合胞病毒住院负担
Can Respir J. 2017;2017:4521302. doi: 10.1155/2017/4521302. Epub 2017 Nov 7.
2
Time and out-of-pocket costs associated with respiratory syncytial virus hospitalization of infants.与婴儿呼吸道合胞病毒住院相关的时间和自付费用。
Value Health. 2003 Mar-Apr;6(2):100-6. doi: 10.1046/j.1524-4733.2003.00220.x.
3
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.呼吸道合胞病毒感染对足月儿和早产儿住院治疗的结局及费用影响
J Perinatol. 2016 Nov;36(11):990-996. doi: 10.1038/jp.2016.113. Epub 2016 Aug 4.
4
Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study.加拿大儿童呼吸道合胞病毒感染的经济学评估:加拿大儿科感染研究协作网络(PICNIC)研究
J Pediatr. 1997 Jul;131(1 Pt 1):113-7. doi: 10.1016/s0022-3476(97)70133-1.
5
Medical consumption and socioeconomic effects of infection with respiratory syncytial virus in The Netherlands.荷兰呼吸道合胞病毒感染的医疗消费及社会经济影响
Pediatr Infect Dis J. 2001 Feb;20(2):160-3. doi: 10.1097/00006454-200102000-00008.
6
A method for identifying the financial burden of hospitalized infants on families.一种识别住院婴儿家庭经济负担的方法。
Value Health. 2002 Jan-Feb;5(1):55-9. doi: 10.1046/j.1524-4733.2002.51076.x.
7
Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.加拿大孕33至35足周出生的早产儿呼吸道合胞病毒预防风险评分工具。
Curr Med Res Opin. 2009 Jul;25(7):1585-91. doi: 10.1185/03007990902929112.
8
Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.1998年至2002年帕利珠单抗预防呼吸道合胞病毒疾病:四年使用帕利珠单抗的结果
Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S46-54. doi: 10.1097/01.inf.0000053885.34703.84.
9
Costs of hospitalization with respiratory syncytial virus illness among children aged <5 years and the financial impact on households in Bangladesh, 2010.2010 年孟加拉国<5 岁儿童因呼吸道合胞病毒病住院的费用及对家庭的经济影响
J Glob Health. 2017 Jun;7(1):010412. doi: 10.7189/jogh.07.010412.
10
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.帕利珠单抗是一种人源化呼吸道合胞病毒单克隆抗体,可降低高危婴儿因呼吸道合胞病毒感染而住院的几率。IMpact-RSV研究小组。
Pediatrics. 1998 Sep;102(3 Pt 1):531-7.

引用本文的文献

1
Health economic evaluation of implementing a universal immunization program with nirsevimab compared to standard of care for the prevention of respiratory syncytial virus disease in Canadian infants.与加拿大婴儿预防呼吸道合胞病毒疾病的标准治疗相比,实施含nirsevimab的通用免疫计划的卫生经济评估。
Hum Vaccin Immunother. 2025 Dec;21(1):2480875. doi: 10.1080/21645515.2025.2480875. Epub 2025 Apr 5.
2
Hospital admissions for acute respiratory tract infections among infants from Nunavut and the burden of respiratory syncytial virus: a 10-year retrospective cohort study.努纳武特地区婴儿急性呼吸道感染的住院情况及呼吸道合胞病毒负担:一项10年回顾性队列研究。
Lancet Reg Health Am. 2025 Feb 13;43:101021. doi: 10.1016/j.lana.2025.101021. eCollection 2025 Mar.
3

本文引用的文献

1
Mothers and Fathers in NICU: The Impact of Preterm Birth on Parental Distress.新生儿重症监护病房中的父母:早产对父母痛苦的影响。
Eur J Psychol. 2016 Nov 18;12(4):604-621. doi: 10.5964/ejop.v12i4.1093. eCollection 2016 Nov.
2
Intensive Care Unit Admission and Death Rates of Infants Admitted With Respiratory Syncytial Virus Lower Respiratory Tract Infection in Mexico.墨西哥呼吸道合胞病毒下呼吸道感染入院婴儿的重症监护病房收治率和死亡率
Pediatr Infect Dis J. 2016 Nov;35(11):1199-1203. doi: 10.1097/INF.0000000000001262.
3
Preventing hospitalizations for respiratory syncytial virus infection.
The costs of suboptimal breastfeeding in Ontario, Canada, and potential healthcare resource impacts from improving rates: a pediatric health system costing analysis.加拿大安大略省次优母乳喂养的成本以及提高母乳喂养率对医疗资源的潜在影响:一项儿科卫生系统成本分析
Int Breastfeed J. 2025 Feb 22;20(1):9. doi: 10.1186/s13006-025-00702-y.
4
Cost-effectiveness of nirsevimab and maternal RSVpreF for preventing respiratory syncytial virus disease in infants across Canada.在加拿大,尼塞韦单抗和母体呼吸道合胞病毒前融合蛋白疫苗用于预防婴儿呼吸道合胞病毒疾病的成本效益。
BMC Med. 2025 Feb 21;23(1):102. doi: 10.1186/s12916-025-03928-z.
5
Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel.安大略省用于预防呼吸道合胞病毒(RSV)的尼塞韦单抗项目的优化实施:省级RSV专家小组的建议
Hum Vaccin Immunother. 2024 Dec 31;20(1):2429236. doi: 10.1080/21645515.2024.2429236. Epub 2024 Dec 18.
6
Impact of Child Respiratory Syncytial Virus-Confirmed Infections on Caregivers in Japan: A Web-Based Survey.儿童呼吸道合胞病毒确诊感染对日本护理人员的影响:一项基于网络的调查。
J Clin Med. 2024 Sep 10;13(18):5355. doi: 10.3390/jcm13185355.
7
Neighborhood-Level Burden of Social Risk Factors on Respiratory Syncytial Virus Hospitalization in Ontario, Canada, 2016-2019.2016 - 2019年加拿大安大略省社区层面社会风险因素对呼吸道合胞病毒住院的影响
Open Forum Infect Dis. 2024 Jul 10;11(8):ofae384. doi: 10.1093/ofid/ofae384. eCollection 2024 Aug.
8
Effects of infant bronchiolitis on family life.婴幼儿细支气管炎对家庭生活的影响。
Front Pediatr. 2024 Jun 19;12:1343045. doi: 10.3389/fped.2024.1343045. eCollection 2024.
9
The Multifaceted Burden of Respiratory Syncytial Virus (RSV) Infections in Young Children on the Family: A European Study.幼儿呼吸道合胞病毒(RSV)感染给家庭带来的多方面负担:一项欧洲研究
Infect Dis Ther. 2024 Jul;13(7):1531-1573. doi: 10.1007/s40121-024-00989-0. Epub 2024 May 20.
10
Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study.加拿大预防婴儿呼吸道合胞病毒疾病的尼塞韦单抗和母体呼吸道合胞病毒前融合蛋白疫苗策略的成本效益分析:一项模拟研究
Lancet Reg Health Am. 2023 Nov 9;28:100629. doi: 10.1016/j.lana.2023.100629. eCollection 2023 Dec.
预防呼吸道合胞病毒感染导致的住院治疗。
Paediatr Child Health. 2015 Aug-Sep;20(6):321-33. doi: 10.1093/pch/20.6.321.
4
Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation.婴儿细支气管炎出院研究(BIDS):一项多中心、平行组、双盲、随机对照、等效性试验及经济学评估。
Health Technol Assess. 2015 Sep;19(71):i-xxiii, 1-172. doi: 10.3310/hta19710.
5
Respiratory Syncytial Virus Infection in High-risk Infants - an Update on Palivizumab Prophylaxis.高危婴儿的呼吸道合胞病毒感染——帕利珠单抗预防的最新进展
Open Microbiol J. 2014 Jul 11;8:71-7. doi: 10.2174/1874285801408010071. eCollection 2014.
6
Respiratory syncytial virus infections in infants affected by primary immunodeficiency.婴儿原发性免疫缺陷患者的呼吸道合胞病毒感染。
J Immunol Res. 2014;2014:850831. doi: 10.1155/2014/850831. Epub 2014 Jun 25.
7
Are we too passive in our attempts to prevent respiratory syncytial virus infection in Northern Canada?在加拿大北部预防呼吸道合胞病毒感染的努力中,我们是否过于被动?
Can Respir J. 2014 May-Jun;21(3):163-4. doi: 10.1155/2014/258504.
8
Respiratory syncytial virus--a comprehensive review.呼吸道合胞病毒——全面综述。
Clin Rev Allergy Immunol. 2013 Dec;45(3):331-79. doi: 10.1007/s12016-013-8368-9.
9
Acute care utilization due to hospitalizations for pediatric lower respiratory tract infections in British Columbia, Canada.因小儿下呼吸道感染住院而在加拿大不列颠哥伦比亚省进行的急性护理利用。
BMC Health Serv Res. 2012 Dec 8;12:451. doi: 10.1186/1472-6963-12-451.
10
Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model.使用残疾调整生命年(DALY)模型计算住院患者中最常见呼吸道病毒的疾病负担。
J Clin Virol. 2011 Nov;52(3):215-21. doi: 10.1016/j.jcv.2011.07.017. Epub 2011 Aug 30.